Atherosclerosis: INHIBITING EFFECT OF AN ANTIHISTAMINIC DRUG, CHLORPHENIRAMINE

Circulation Research - United States
doi 10.1161/01.res.11.2.277
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Antihistaminic Effect of Bauhinia Racemosa Leaves

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2011English

Expedient Synthesis of Mequitazine an Antihistaminic Drug by Palladium Catalyzed Allylic Alkylation of Sodium Phenothiazinate

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2009English

Synthesis of Antihistaminic Agents. IV

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1952English

Studies on Antihistaminic Agents. IV

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1951English

Studies on Antihistaminic Agents. VI

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1952English

Studies on Antihistaminic Agents. V

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1952English

Preserving LXR by Inhibiting T39: A Step Closer to Treating Atherosclerosis and Steatohepatitis?

Hepatology
MedicineHepatology
2016English

Inhibiting LXRα Phosphorylation in Hematopoietic Cells Reduces Inflammation and Attenuates Atherosclerosis and Obesity

2020English

Resveratrol Blocks Atherosclerosis Development by Inhibiting IL-1β in Macrophages Induced by Cholesterol

Archives of Biological Sciences
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy